An Fc‐optimized NKG2D‐immunoglobulin G fusion protein for induction of natural killer cell reactivity against leukemia

E-ISSN： 1097-0215|136|5|1073-1084

ISSN： 0020-7136

Source： INTERNATIONAL JOURNAL OF CANCER, Vol.136, Iss.5, 2015-03, pp. : 1073-1084

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Umbilical cord blood plasma contains soluble NKG2D ligands that mediate loss of natural killer cell function and cytotoxicity

EUROPEAN JOURNAL OF IMMUNOLOGY, Vol. 45, Iss. 8, 2015-08 ,pp. : 2324-2334

John Wiley & Sons Inc

Access to resources Recommend Favorite

Transforming growth factor-β1 regulates human renal proximal tubular epithelial cell susceptibility to natural killer cells via modulation of the NKG2D ligands

International Journal of Molecular Medicine, Vol. 36, Iss. 4, 2015-01 ,pp. : 1180-1188

Spandidos Publications

Access to resources Recommend Favorite

Natural killer cell therapy in children with relapsed leukemia

PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol. 62, Iss. 8, 2015-08 ,pp. : 1468-1472

John Wiley & Sons Inc

Access to resources Recommend Favorite

Transfer of the human NKG2D ligands UL16 binding proteins (ULBP) 1–3 is related to lytic granule release and leads to ligand retransfer and killing of ULBP‐recipient natural killer cells

IMMUNOLOGY, Vol. 146, Iss. 1, 2015-09 ,pp. : 70-80

John Wiley & Sons Inc

Access to resources Recommend Favorite

The natural killer–activating receptor, NKG2D, on CD3+CD8+ T cells plays a critical role in identifying and killing autologous myeloma cells

TRANSFUSION, Vol. 54, Iss. 6, 2014-06 ,pp. : 1515-1521

John Wiley & Sons Inc

Access to resources Recommend Favorite